In-silico analysis identifies bioactive compounds from fruits as p-glycoprotein inhibitors, suggesting potential for overcoming drug resistance.
Introduction: P-glycoprotein is a crucial efflux transporter whose overexpression contributes to drug resistance, hindering effective treatment of various diseases. Objective: This study aims to identify the inhibitory bioactive fruit components on p-glycoprotein, which could potentially overcome drug resistance. Methodology: 150 bioactive components were identified from 40 regional fruits from India. The druggability and pharmacokinetic profiles of the components were examined, revealing 8 potential inhibitors. Molecular docking was performed to identify the most suitable inhibitor, which was then subjected to simulation to validate its interaction with p-glycoprotein. Result: According to our research, Δ5-Avenasterol (−79.5 kcal/mol) and Phyllanthin (−78.8 kcal/mol) have a comparable binding affinity to the control inhibitor rifampin (−73.6 kcal/mol), making them appropriate inhibitors for p-glycoprotein. Conclusion: The conformational stability of the most effective inhibitory drugs inside the p-glycoprotein structure was evaluated using molecular dynamics simulations. This research may lead to the development of novel natural p-glycoprotein inhibitors, providing a promising strategy for combating multidrug resistance.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: